Literature DB >> 27500000

2016 Respiratory Effectiveness Group Annual Summit Report-impact & influence of real-world respiratory evidence.

Alison Chisholm1, Nemr Eid2, Bernardino Alcázar-Navarrete3, Aji Barot4, George Christoff5, David B Price6.   

Abstract

Entities:  

Year:  2016        PMID： 27500000      PMCID： PMC4958754          DOI： 10.21037/jtd.2016.07.16

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  29 in total

1.  Inhaled corticosteroids in COPD: a case in favour.

Authors:  D S Postma; P Calverley
Journal:  Eur Respir J       Date:  2009-07       Impact factor: 16.671

2.  GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.

Authors:  Gordon H Guyatt; Andrew D Oxman; Gunn E Vist; Regina Kunz; Yngve Falck-Ytter; Pablo Alonso-Coello; Holger J Schünemann
Journal:  BMJ       Date:  2008-04-26

3.  Differential effects of inhaled corticosteroids in smokers/ex-smokers and nonsmokers with asthma.

Authors:  Nicolas Roche; Dirkje S Postma; Gene Colice; Anne Burden; Theresa W Guilbert; Elliot Israel; Richard J Martin; Willem M C van Aalderen; Jonathan Grigg; Elizabeth V Hillyer; Julie von Ziegenweidt; David B Price
Journal:  Am J Respir Crit Care Med       Date:  2015-04-15       Impact factor: 21.405

4.  The concept of control in COPD: a new proposal for optimising therapy.

Authors:  Juan José Soler-Cataluña; Bernardino Alcázar-Navarrete; Marc Miravitlles
Journal:  Eur Respir J       Date:  2014-07-25       Impact factor: 16.671

5.  Quality standards for real-world research. Focus on observational database studies of comparative effectiveness.

Authors:  Nicolas Roche; Helen Reddel; Richard Martin; Guy Brusselle; Alberto Papi; Mike Thomas; Dirjke Postma; Vicky Thomas; Cynthia Rand; Alison Chisholm; David Price
Journal:  Ann Am Thorac Soc       Date:  2014-02

6.  Leukotriene antagonists as first-line or add-on asthma-controller therapy.

Authors:  David Price; Stanley D Musgrave; Lee Shepstone; Elizabeth V Hillyer; Erika J Sims; Richard F T Gilbert; Elizabeth F Juniper; Jon G Ayres; Linda Kemp; Annie Blyth; Edward C F Wilson; Stephanie Wolfe; Daryl Freeman; H Miranda Mugford; Jamie Murdoch; Ian Harvey
Journal:  N Engl J Med       Date:  2011-05-05       Impact factor: 91.245

7.  Comorbidity in severe asthma requiring systemic corticosteroid therapy: cross-sectional data from the Optimum Patient Care Research Database and the British Thoracic Difficult Asthma Registry.

Authors:  Joan Sweeney; Chris C Patterson; Andrew Menzies-Gow; Rob M Niven; Adel H Mansur; Christine Bucknall; Rekha Chaudhuri; David Price; Chris E Brightling; Liam G Heaney
Journal:  Thorax       Date:  2016-01-27       Impact factor: 9.139

8.  A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.

Authors:  Talmadge E King; Williamson Z Bradford; Socorro Castro-Bernardini; Elizabeth A Fagan; Ian Glaspole; Marilyn K Glassberg; Eduard Gorina; Peter M Hopkins; David Kardatzke; Lisa Lancaster; David J Lederer; Steven D Nathan; Carlos A Pereira; Steven A Sahn; Robert Sussman; Jeffrey J Swigris; Paul W Noble
Journal:  N Engl J Med       Date:  2014-05-18       Impact factor: 91.245

9.  Comparing the effectiveness of small-particle versus large-particle inhaled corticosteroid in COPD.

Authors:  Dirkje S Postma; Nicolas Roche; Gene Colice; Elliot Israel; Richard J Martin; Willem Mc van Aalderen; Jonathan Grigg; Anne Burden; Elizabeth V Hillyer; Julie von Ziegenweidt; Gokul Gopalan; David Price
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-10-17

10.  Measuring lung function using sound waves: role of the forced oscillation technique and impulse oscillometry system.

Authors:  Bill Brashier; Sundeep Salvi
Journal:  Breathe (Sheff)       Date:  2015-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.